Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC)

被引:20
作者
Angelini, Giulia [1 ]
Marini, Carolina [2 ]
Iacconi, Chiara [3 ]
Mazzotta, Dionisia [2 ]
Moretti, Monica [2 ]
Picano, Eugenia [2 ]
Morganti, Riccardo [4 ]
机构
[1] Dept Translat Res & New Technol Med & Surg Diagno, I-56124 Pisa, Italy
[2] Univ Pisana, Azienda Osped, Dept Radiol, Via Roma 67, I-56100 Pisa, Italy
[3] USL1 Massa Carrara, Breast Unit, Dept Radiol, Piazza Monzoni 2, I-54033 Carrara, Italy
[4] Univ Hosp S Chiara, Dept Oncol, Biostat Consulting, Pisa, Italy
关键词
IMAGING FEATURES; NEOADJUVANT CHEMOTHERAPY; ASSOCIATION; SURVIVAL; SOCIETY;
D O I
10.1016/j.clinimag.2017.10.016
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Few reports in literature describe triple negative breast cancer (TNBC) imaging findings. Aim of the study is to determine MR-features of TNBC compared to receptor positive cancer (nTNBC). From May 2014 to May 2015, we retrospectively enrolled 31 consecutive patients with histological diagnosis of TNBC and a control group of 31 consecutive nTNBC observed in the same period, out of 602 cancer, diagnosed in our department in the same year. Histopathological analysis and MR-features of TNBC (31 patients) were compared to nTNBC (31 patients). MR-features included dimension, fibroglandular tissue (FGT), background parenchimal enhancement (BPE), mass shape, margins, presence of rim, intratumoral signal intensity in T2w, uni-multifocality, kinetic curves. All patients were examined with MR 1,5 T (Magnetom Simphony Tim, Siemens Healthcare) performing T2w fat-sat and contrast enhanced high temporal and spatial resolution Tlw before and after injection of Gadolinium. 62 staging MR were reviewed. Median age was 50 (30-78ys) with a standard deviation of 10,9. TNBC showed 3 MR features in concordance with current literature: rim enhancement, hyperintensity in T2 sequence and unifocality. Rim enhancement was shown in 67.7% of TNBC (21/31) and 29% of nTNBC (9/31). Higher T2w values were shown in 83.9% of TNBC (26/31) and 58.1% of nTNBC (18/31). Cancer was multifocal in 7/31 (22.6%) of TNBC and 19/31 (61.3%) nTNBC. No correlation was found for dimension (p = 0.12), FGT = 0.959), BPE (p = 0.596), homogeneity of enhancement (p = 0.43), margins (p = 0.671) and kinetic (p = 0.37). Multivariate analysis demonstrated that rim enhancement and unifocality correlated independently with TNBC group. Area under ROC curve of our model is 0.835. Furthermore, we evaluated the clinical outcome of all 31 TNBC patients in a follow-up time ranging from 24 months to 36 months separating them in a free-survival group (23 women) and a recurrence group (8 women with local recurrence or distant metastasis): only kinetic curves resulted to be significantly higher in recurrence group (p = 0.042).
引用
收藏
页码:12 / 16
页数:5
相关论文
共 25 条
  • [1] Significance of Breast Lesion Descriptors in the ACR BI-RADS MRI Lexicon
    Agrawal, Garima
    Su, Min-Ying
    Nalcioglu, Orhan
    Feig, Stephen A.
    Chen, Jeon-Hor
    [J]. CANCER, 2009, 115 (07) : 1363 - 1380
  • [2] [Anonymous], 2013, American College of Radiology Breast Imaging Reporting and Data System (BI-RADS)., V5th
  • [3] Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival
    Bae, Min Sun
    Shin, Sung Ui
    Ryu, Han Suk
    Han, Wonshik
    Im, Seock-Ah
    Park, In-Ae
    Noh, Dong-Young
    Moon, Woo Kyung
    [J]. RADIOLOGY, 2016, 281 (02) : 392 - 400
  • [4] Heterogeneity of triple-negative breast cancer: mammographic, US, and MR imaging features according to androgen receptor expression
    Bae, Min Sun
    Park, So Yeon
    Song, Sung Eun
    Kim, Won Hwa
    Lee, Su Hyun
    Han, Wonshik
    Park, In-Ae
    Noh, Dong-Young
    Moon, Woo Kyung
    [J]. EUROPEAN RADIOLOGY, 2015, 25 (02) : 419 - 427
  • [5] Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer
    Baltzer, Pascal A. T.
    Vag, Tibor
    Dietzel, Matthias
    Beger, Sebastian
    Freiberg, Christian
    Gajda, Mieczyslaw
    Camara, Oumar
    Kaiser, Werner A.
    [J]. EUROPEAN RADIOLOGY, 2010, 20 (07) : 1563 - 1571
  • [6] Metabolic characterization of triple negative breast cancer
    Cao, Maria D.
    Lamichhane, Santosh
    Lundgren, Steinar
    Bofin, Anna
    Fjosne, Hans
    Giskeodegard, Guro F.
    Bathen, Tone F.
    [J]. BMC CANCER, 2014, 14
  • [7] Association between survival in patients with primary invasive breast cancer and computer aided MRI
    Dietzel, Matthias
    Zoubi, Ramy
    Vag, Tibor
    Gajda, Mieczyslaw
    Runnebaum, Ingo B.
    Kaiser, Werner A.
    Baltzer, Pascal A.
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2013, 37 (01) : 146 - 155
  • [8] Imaging of triple-negative breast cancer
    Dogan, B. E.
    Turnbull, L. W.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 23 - 29
  • [9] Multimodality Imaging of Triple Receptor-Negative Tumors With Mammography, Ultrasound, and MRI
    Dogan, Basak E.
    Gonzalez-Angulo, Ana Maria
    Gilcrease, Michael
    Dryden, Mark J.
    Yang, Wei Tse
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (04) : 1160 - 1166
  • [10] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    Dowsett, Mitch
    Allred, D. Craig
    Hagerty, Karen L.
    Badve, Sunil
    Fitzgibbons, Patrick L.
    Francis, Glenn
    Goldstein, Neil S.
    Hayes, Malcolm
    Hicks, David G.
    Lester, Susan
    Love, Richard
    Mangu, Pamela B.
    McShane, Lisa
    Miller, Keith
    Osborne, C. Kent
    Paik, Soonmyung
    Perlmutter, Jane
    Rhodes, Anthony
    Sasano, Hironobu
    Schwartz, Jared N.
    Sweep, Fred C. G.
    Taube, Sheila
    Torlakovic, Emina Emilia
    Valenstein, Paul
    Viale, Giuseppe
    Visscher, Daniel
    Wheeler, Thomas
    Williams, R. Bruce
    Wittliff, James L.
    Wolff, Antonio C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2784 - 2795